Concepedia

F. R. Ahmann

FR

Statistics

Publications

7

Citations

652

H-Index

7

Active since

1986

Affiliations

University of Arizona(Current)

University at Buffalo, State University of New York

Roswell Park Comprehensive Cancer Center

F. R. Ahmann is an author at University of Arizona specializing in medicine, oncology, and prostate cancer.

Publications per year

1986–2008

7

Publications

7

Palliation of pain associated with metastatic bone cancer using samarium-153 lexidronam: a double-blind placebo-controlled clinical trial.

A. N. Serafini, S. J. Houston, I. Resche et al. · Journal of Clinical Oncology · 1998 · 433 citations

, , +17

MVA-MUC1-IL2 vaccine immunotherapy (TG4010) improves PSA doubling time in patients with prostate cancer with biochemical failure

Robert Dreicer, Walter M. Stadler, F. R. Ahmann et al. · Investigational New Drugs · 2008 · 80 citations

, , +15

Selenium and inhibition of disease progression in men diagnosed with prostate carcinoma: study design and baseline characteristics of the ‘Watchful Waiting’ Study

M. Suzanne Stratton, Marvin Reid, G. Schwartzberg et al. · Anti-Cancer Drugs · 2003 · 48 citations

, , +16

Selenium and prevention of prostate cancer in high-risk men: the Negative Biopsy Study

M. Suzanne Stratton, Marvin Reid, G. Schwartzberg et al. · Anti-Cancer Drugs · 2003 · 44 citations

, , +17

Extensive non-small cell lung cancer treated with mitomycin, cisplatin, and vindesine (MiPE): a Southwest Oncology Group Study.

Thomas P. Miller, Ralph Vance, F. R. Ahmann et al. · PubMed · 1986 · 23 citations

, , +11

1–5 of 7